Clinical utility of single molecule counting technology for quantification of KIM-1 in patients with heart failure and chronic kidney disease

Plasma KIM-1 is quantifiable in healthy volunteers, elevated in CKD and CHF patients, and correlates with eGFR. Additional investigation is needed to determine if KIM-1 provides prognostic value for CKD and CHF patient outcomes.